Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
The New England Journal of Medicine|July 31, 1998
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study GroupK G Saag, R Emkey, T J Schnitzer, et al.
Osteoarthritis and Cartilage|June 24, 2008
Serum protein signatures detect early radiographic osteoarthritisS M Ling, D D Patel, P Garnero, et al.
The Journal of Clinical Endocrinology and Metabolism|May 8, 2002
Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trialP J Meunier, D O Slosman, P D Delmas, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 25, 2010
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standardsS Vasikaran, R Eastell, O Bruyère, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 30, 2008
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient dataA Cranney, G A Wells, E Yetisir, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 7, 2002
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosisP D Delmas, G Calvo, M Boers, et al.
Arthritis and Rheumatism|June 1, 2006
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destructionP P Geusens, R B M Landewé, P Garnero, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 6, 2009
Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture TrialR Eastell, T Lang, S Boonen, et al.
Archives of Internal Medicine|December 9, 2000
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trialsC C Johnston, N H Bjarnason, F J Cohen, et al.
Annals of the Rheumatic Diseases|December 13, 2005
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJ-Y Reginster, S Adami, P Lakatos, et al.
Pageof 42